Clinical Study

Hepatectomy Based on Future Liver Remnant Plasma Clearance Rate of Indocyanine Green

Table 3

Patient characteristics according to PHLF grade.

VariablesNon-PHLF ()PHLF Grade A ()PHLF Grade B () value

Age, years69 (38–82)68 (40–86)69 (56–93)0.59
Sex, male, %75.055.8750.12
HBs antigen+, %14.511.66.30.68
HCV antibody+, %10.411.631.30.10
ICGK0.154 (0.069–0.212)0.156 (0.091–0.264)0.137 (0.085–0.211)0.21
ICGR15, %9.9 (4.2–35.4)10.2 (1.9–25.6)12.9 (4.2–27.8)0.39
TLV, mL1214 (786–2025)1133 (735–2086)1320 (829–2169)0.39
% RLV68.9 (40.5–93.7)55.9 (34.7–87.0)44.0 (37.2–80.2)<0.001
rICGK0.095 (0.053–0.199)0.079 (0.050–0.153)0.067 (0.050–0.088)<0.001
T-Bil, mg/dL0.5 (0.2–2.5)0.7 (0.3–1.9)0.7 (0.4–2.2)0.74
Alb, g/dL4.1 (1.8–5.2)4.1 (2.6–4.7)3.9 (3.0–4.7)0.31
Plt, 104/μL19.4 (8.3–72.0)17.0 (9.7–41.5)17.7 (8.6–45.5)0.68
PT-INR1.03 (0.93–1.93)1.03 (0.94–1.35)1.06 (0.94–1.31)0.93
eGFR (mL/min)75.8 (53.2–124.4)74.1 (6.5–186.0)69.3 (38.9–120.4)0.54
Blood loss, mL440 (50–2600)500 (70–7750)1385 (230–3400)0.047
Operation time, min328 (151–654)348 (204–620)401 (286–748)0.02

values between the three groups were assessed by one-way analysis of variance and the Tukey multiple comparison procedure.